NCT06914674View on ClinicalTrials.gov

Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2028

Conditions
Pancreatic Neoplasms
Interventions
DRUG

Tamoxifen 20 mg

Tamoxifen: 10 mg orally twice daily. Combination therapy: Chemotherapy, radiotherapy, surgery, or other treatments per NCCN guidelines and patient condition.

Trial Locations (1)

200032

RECRUITING

Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER